# Chemical Synthesis and High-Throughput Analytics Shared Resource

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $140,570

## Abstract

CORE 005 – CHEMICAL SYNTHESIS AND HIGH-THROUGHPUT ANALYTICS SHARED
RESOURCE
PROJECT SUMMARY/ABSTRACT
The Vanderbilt Chemical Synthesis and High-throughput Analytics Shared Resource (CSHTASR) provides
state-of-the-art capabilities for the Vanderbilt-Ingram Cancer Center (VICC) research community, inclusive of
our VICC members and partners at Meharry Medical College, Tennessee State University, and other NCI Cancer
Centers. CSHTASR works to harness the power of chemistry and assay technologies to support research
requiring the application or discovery of chemical tools to answer biological questions. Projects supported by this
shared resource include:
 • Medicinal chemistry; including hit optimization and hit-to-lead activities, as well as discovery of novel
 compounds for pre-clinical or hypothesis-driven in vitro studies
 • Large-scale synthesis (10-100 grams) and compound formulation to support in vivo animal studies
 • Synthesis of isotopically labeled compounds including metabolites for mass spectral quantification in
 clinical samples
 • Synthesis and design of affinity and fluorescent probes
 • Synthesis of natural and unnatural nucleotides and peptides
 • High-throughput instrumentation that provides static and kinetic readouts for multiple assays including
 biochemical, cell-based, phenotypic, high-content image-based, 3D culture models, and whole
organisms
 • Functional genomic screens to identify novel drug targets and mechanism(s) of drug action/resistance
 • Kinetic assays to support complex dynamic models
 • “Focused” compound/drug library screening and drug combinations – e.g., FDA drug collection (1,300),
 anti-cancer set (>1,000), etc., for translational projects
 • Full high-throughput screening campaigns of diverse, large (>350,000) compound libraries, which is
 coordinated with medicinal chemistry to discover new chemistry and novel compounds for disease-
 related targets.
The CSHTASR provides these services through a combination of instrument technology and staff expertise.
Institutional and NIH funds have been invested to acquire leading-edge instrumentation required for effective
and efficient CSHTASR services. In addition, our compound and FGS libraries are valuable material resources
that allow interrogation of biological activity, providing insight into target/pathway identification and starting points
for chemical probe optimization. The CSHTASR employs a highly trained leadership and support staff with
extensive experience and expertise in advanced chemistry techniques and HTS methodologies.

## Key facts

- **NIH application ID:** 10024636
- **Project number:** 2P30CA068485-25
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Gary ALLEN Sulikowski
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $140,570
- **Award type:** 2
- **Project period:** 1998-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10024636

## Citation

> US National Institutes of Health, RePORTER application 10024636, Chemical Synthesis and High-Throughput Analytics Shared Resource (2P30CA068485-25). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10024636. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*